GleamWall
中文EN

SLDB Solid Biosciences Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1707502 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-28.8%
TTM EPS YoY29.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-76.9%
ROA-64.9%
ROIC (approx.)-94.0%
Asset turnover—

Leverage & solvency

Liabilities / assets12.3%
Debt / equity0.00x
Current ratio11.99x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.92x
Accruals ratio-4.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue——
R&D expense$140.32M$96.43M
SG&A expense$38.88M$33.30M
Operating income-$179.21M-$129.73M
Interest expense-$203,000$340,000
Pretax income-$174.20M-$124.58M
Income tax$0$0
Net income-$174.32M-$124.70M
EBITDA-$177.57M-$127.27M
EPS (basic)-1.99-3.06
EPS (diluted)-1.99-3.06
Weighted avg. shares (diluted)87.50M40.82M
Balance sheet
Cash & equivalents$59.90M$82.19M
Short-term investments$127.95M$68.69M
Current assets$205.46M$157.30M
PP&E, net$4.17M$4.75M
Total assets$232.54M$188.66M
Current liabilities$33.47M$30.26M
Total liabilities$52.53M$51.42M
Shareholders' equity$180.01M$137.25M
Shares outstanding78.97M40.47M
Cash flow statement
Operating cash flow-$156.29M-$100.01M
Capital expenditure$1.15M$654,000
Free cash flow-$157.44M-$100.67M
Investing cash flow-$58.45M-$16.09M
Financing cash flow$194.45M$122.44M
Depreciation & amortization$1.64M$2.46M
Stock-based compensation$16.91M$10.52M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.